ESRRA and ovarian serous carcinoma: They used deep paired-end sequencing to detect the fusion gene ESRRA–C11orf20 in 10 out of 67 (15%) serous ovarian carcinomas examined, a finding that holds great promise for our understanding of ovarian tumorigenesis as well as, potentially, for new treatment strategies.